Are individuals that took Actos, ActoPlus Met, ActoPlus Met XR or Duetact in danger of bladder cancer? Patients that have taken these drugs and which have been diagnosed with bladder cancer may have a legal claim for compensation. The FDA made a safety announcement concerned Actos and bladder cancer. Patients taking pioglitazone for more than a year may have an increased risk of developing cancerous tumors of the bladder. Pioglitazone is found in these diabetes drugs. People have alleged that the drug maker Takeda Pharmaceutical did not disclose information about the Actos bladder cancer risk. According to at least one source, it is claimed that there were allegations the Takeda failed to provide adequate warnings with its diabetes drug.